Amiram Katz, MD, DABPN

A renowned neurologist, Amiram Katz, MD, DABPN holds 40 years of professional experience in the medical field, with 20 years as the president of MedAhead, Inc in Orange, Connecticut. Throughout his extensive career, he has set himself apart working in the areas of diving and hyperbaric medicine, seizure disorders and sleep medicine, Lyme disease, multiple sclerosis, as well as Alzheimer’s disease. His daily work sees him providing medical care, consultations, and research and development in these areas, as well as developing and marketing proprietary medical devices and treatments. Dr. Katz has also been a consulting neurologist at Norwalk Hospital in Norwalk, Connecticut since 2004.

Over the course of his career, Dr. Katz has offered his expertise to various medical centers and institutions such as Southport Neurology, Neurology Associates of Norwalk, Telemedicine Consultants of America and the Epilepsy Foundation of Connecticut. Notably, he served as commanding officer of the Israeli Navy Medical and Hyperbaric Institute and was the youngest chief of neurology at Central Emek Hospital in Afula, Israel. He was recently invited to serve on the board for the Foundation for Total Recovery in McLean, Virginia, and the advisory board for the Global Lyme Alliance. Named a Top Doctor in the New York Metro Area by Castle Connolly from 2002 to 2014, Dr. Katz attributes his success to a passion for his work and providing his patients with the best individualized medical outcome for their illness and conditions.

At the start of his career, Dr. Katz was an extern in medicine at Bellevue Hospital in 1973 and obtained a Doctor of Medicine, magna cum laude, from the Sackler School of Medicine at Tel Aviv University in 1976. He then completed a residency in internal medicine at Sheba Medical Center and a fellowship in clinical polysomnography at the University of Haifa by 1985. Upon his arrival to the United States, he completed a fellowship in clinical neurophysiology at Cleveland Clinic, as well as a fellowship and residency in clinical epilepsy at the Yale School of Medicine by 1991.

Upon reflection, Dr. Katz considers a highlight of his career was getting his first medical device patented and manufactured, FlowKeepers, registered with the U.S. Patent Office. In the coming years, he intends to continue to provide top-quality medical care to his patients from a practice aspect, and experience continued growth and success from a clinical research aspect with his current clinical trials in Lyme disease, Alzheimer’s disease and Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease. Dr. Katz is currently in the process of launching a device that will improve circulation in the legs.